Gateway Analytical and Aptar Pharma Prepare to Showcase Integrated Drug Delivery & Analytical Solutions at PDA Week 2026
PDA WEEK – DENVER, CO –...
Gateway Analytical Prepares for PDA Week 2026: Let’s Talk Particulates, CCI, and 2026 Regulatory Readiness!
Are you attending PDA Week 2026,...
Forensic Particulate Investigations: Navigating Quality Control Obstacles
When Quality Control (QC) identifies an...
Closing the USP <1790> Gap: Demonstrating Inspection Adequacy for DIPs
As we face the new regulatory...
The Gateway Analytical Journal – Monthly Roundtable – Issue 01 // January 2026
Welcome to the Gateway Analytical Monthly...
Beyond Compliance: Navigating the Future of USP <382> and <661>
With the 2025 regulatory deadlines now...
USP <382> Is Now in Effect. Here’s What Your Team Needs to Do Next.
As of December 1, 2025, USP...
Are Your Drug Products Ready for the December 1st, 2025 USP <661> Deadline?
The clock is ticking! The compliance...
Key Takeaways & FAQs from Our Webinar: USP <382> Deadline Readiness
With the USP <382> deadline still...